Xiaoyuan Lu

521 total citations
25 papers, 441 citations indexed

About

Xiaoyuan Lu is a scholar working on Molecular Biology, Cancer Research and Organic Chemistry. According to data from OpenAlex, Xiaoyuan Lu has authored 25 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Cancer Research and 7 papers in Organic Chemistry. Recurrent topics in Xiaoyuan Lu's work include Cancer-related molecular mechanisms research (8 papers), RNA modifications and cancer (7 papers) and Circular RNAs in diseases (6 papers). Xiaoyuan Lu is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), RNA modifications and cancer (7 papers) and Circular RNAs in diseases (6 papers). Xiaoyuan Lu collaborates with scholars based in China, Czechia and United States. Xiaoyuan Lu's co-authors include Hai‐Liang Zhu, Robert M. Pearlstein, Zhong‐Chang Wang, Fa-Qian Shen, Shen‐Zhen Ren, Sicong Liu, Ruo‐Jun Man, Xiaoqiang Yan, Pengfei Wang and Juan Sun and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and RSC Advances.

In The Last Decade

Xiaoyuan Lu

24 papers receiving 428 citations

Peers

Xiaoyuan Lu

PHARM

PRM

Aixiao Li United States

Raj Betageri United States

Scott I. Klein United States

Michael Friedmann United States

Alissa A. Hare United States

Julian Levell United States

Michael B. Webb United Kingdom

Jahnabi Roy United States

Ramakrishna Edupuganti United States

Hideyuki Mototani Japan

Aixiao Li United States

Xiaoyuan Lu

213 ×0.9

116 ×0.6

83 ×0.8

8 ×0.1

PHARM

28 ×0.7

PRM

Citations per year, relative to Xiaoyuan Lu Xiaoyuan Lu (= 1×) peers Aixiao Li

Countries citing papers authored by Xiaoyuan Lu

Since Specialization

Citations

This map shows the geographic impact of Xiaoyuan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyuan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyuan Lu more than expected).

Fields of papers citing papers by Xiaoyuan Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyuan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyuan Lu. The network helps show where Xiaoyuan Lu may publish in the future.

Co-authorship network of co-authors of Xiaoyuan Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyuan Lu. A scholar is included among the top collaborators of Xiaoyuan Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyuan Lu. Xiaoyuan Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cao, Lina, Xiaoyuan Lu, Yi‐Jun Wang, & Luyao Wang. (2025). Analysis of Lymph Node Metastasis and Risk Factors in 424 Patients with Low-Grade Endometrioid Endometrial Carcinomas. Gynecologic and Obstetric Investigation. 91(1). 56–64.

Cao, Lina, et al.. (2024). Application of Shear Wave Elastography in the Diagnosis and Evaluation of Cervical Cancer. SHILAP Revista de lepidopterología. 51(9). 1 indexed citations

Lu, Miao, et al.. (2024). FHL1 Inhibition by miR-1301-3p Promotes Uterine Corpus Endometrial Carcinoma Cell Proliferation and Migration: A Prognostic Insight. Current Medicinal Chemistry. 32(36). 8118–8133. 2 indexed citations

Wang, Haihong, et al.. (2023). NOTCH Pathway Genes in Ovarian Cancer: Clinical Significance and Associations with Immune Cell Infiltration. Frontiers in Bioscience-Landmark. 28(9). 220–220. 4 indexed citations

Lu, Xiaoyuan, et al.. (2023). PAXIP1-AS1 is associated with immune infiltration and predicts poor prognosis in ovarian cancer. PLoS ONE. 18(8). e0290031–e0290031. 10 indexed citations

Jin, Xin, et al.. (2021). Expression, Clinical Significance, and Prospective Pathway Signaling of miR-501-3p in Ovarian Cancer Based on Database and Informatics Analysis. International Journal of General Medicine. Volume 14. 5193–5201. 8 indexed citations

Lu, Xiaoyuan, et al.. (2021). Bioinformatics Analysis of KIF1A Expression and Gene Regulation Network in Ovarian Carcinoma. International Journal of General Medicine. Volume 14. 3707–3717. 19 indexed citations

Liu, Sicong, et al.. (2021). Differential Expression Profiles and Function Prediction of Transfer RNA‐Derived Fragments in High‐Grade Serous Ovarian Cancer. BioMed Research International. 2021(1). 5594081–5594081. 13 indexed citations

Lu, Xiaoyuan, et al.. (2021). MiR-585-3p suppresses tumor proliferation and migration by directly targeting CAPN9 in high grade serous ovarian cancer. Journal of Ovarian Research. 14(1). 90–90. 21 indexed citations

10.

Zhao, Changhong, Xuebin Song, & Xiaoyuan Lu. (2020). <p>Directional Osteo-Differentiation Effect of hADSCs on Nanotopographical Self-Assembled Polystyrene Nanopit Surfaces</p>. International Journal of Nanomedicine. Volume 15. 3281–3290. 11 indexed citations

11.

Xu, Hao, et al.. (2019). LINC01170 promotes the progression of endometrial carcinoma by activating the AKT pathway.. PubMed. 23(6). 1745–1752. 7 indexed citations

12.

Sun, Juan, Shen‐Zhen Ren, Xiaoyuan Lu, et al.. (2017). Discovery of a series of 1,3,4-oxadiazole-2(3H)-thione derivatives containing piperazine skeleton as potential FAK inhibitors. Bioorganic & Medicinal Chemistry. 25(9). 2593–2600. 47 indexed citations

13.

Lu, Xiaoyuan, Zhong‐Chang Wang, Shen‐Zhen Ren, et al.. (2016). Coumarin sulfonamides derivatives as potent and selective COX-2 inhibitors with efficacy in suppressing cancer proliferation and metastasis. Bioorganic & Medicinal Chemistry Letters. 26(15). 3491–3498. 76 indexed citations

14.

Lu, Xiaoyuan, et al.. (2016). Design, synthesis and evaluation of benzenesulfonamide-substituted 1,5-diarylpyrazoles containing phenylacetohydrazide derivatives as COX-1/COX-2 agents against solid tumors. RSC Advances. 6(27). 22917–22935. 14 indexed citations

15.

Chen, Zhong, Zhong‐Chang Wang, Xiaoqiang Yan, et al.. (2015). Design, synthesis, biological evaluation and molecular modeling of dihydropyrazole sulfonamide derivatives as potential COX-1/COX-2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(9). 1947–1951. 36 indexed citations

16.

Yan, Xiaoqiang, Zhong‐Chang Wang, Zhen Li, et al.. (2015). Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis. Bioorganic & Medicinal Chemistry Letters. 25(20). 4664–4671. 25 indexed citations

17.

Yang, Hui, et al.. (2014). Novel pyrazoline derivatives as bi-inhibitor of COX-2 and B-Raf in treating cervical carcinoma. Bioorganic & Medicinal Chemistry. 22(15). 4109–4118. 28 indexed citations

18.

Lu, Xiaoyuan, Xuan Ding, & Jing Li. (2014). Effect of Mechanism of Action of Different ω-6/ω-3 Polyunsaturated Fatty Acids Ratio on the Growth of Endometrial Carcinoma Mice. Cell Biochemistry and Biophysics. 71(3). 1671–1676. 6 indexed citations

19.

Lu, Xiaoyuan. (2010). Effects of RNA interference targeting OPN on the in vitro proliferation of human ovarian cancer cell line HO-8910PM. 1 indexed citations

20.

Lu, Xiaoyuan, et al.. (2008). [Effects of WWOX gene transfection on cell growth of epithelial ovarian cancer].. PubMed. 43(5). 361–5. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact